Detection and Clinical Significance of Thrombomodulin in Both Plasma and Tissue Extracts of Cancer Patients.

Xiaohua Xu(Chinese PLA General Hospital), Xiaoying Zhao(Handan College), Xiaohong Zhang(Harbin Engineering University), Xingguo Lu(Second Affiliated Hospital of Zhejiang University), Liansheng Huang(Second Affiliated Hospital of Zhejiang University)
Blood
November 16, 2004
10.1182/blood.v104.11.3966.3966
Cited by 1

Related Papers

HDAC6 Modulates Cell Motility by Altering the Acetylation Level of Cortactin
|Molecular Cell|2007|731
MYC/BCL2 protein coexpression contributes to the inferior survival of activated B-cell subtype of diffuse large B-cell lymphoma and demonstrates high-risk gene expression signatures: a report from The International DLBCL Rituximab-CHOP Consortium Program
|Blood|2013|683
Strategies for Preparing Albumin-based Nanoparticles for Multifunctional Bioimaging and Drug Delivery
|Theranostics|2017|436
Mutational profile and prognostic significance of TP53 in diffuse large B-cell lymphoma patients treated with R-CHOP: report from an International DLBCL Rituximab-CHOP Consortium Program Study
|Blood|2012|396
SIRT1 Regulates the Function of the Nijmegen Breakage Syndrome Protein
|Molecular Cell|2007|272